WEKO3
アイテム
Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG, and a novel dose conversion method, RAP
https://repo.qst.go.jp/records/81168
https://repo.qst.go.jp/records/8116840d2cef1-aab4-4166-97c2-2c07f52c65cd
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2020-07-14 | |||||
| タイトル | ||||||
| タイトル | Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG, and a novel dose conversion method, RAP | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Sakashita, Tetsuya
× Sakashita, Tetsuya× Watanabe, Shigeki× Hirohumi, Hanaoka (Gunma Univ)× Oshima, Yasuhiro× Ikoma, Yoko× Naoyuki, Ukon (Fukushima Med Univ)× Sasaki, Ichiro× Higashi, Tatsuya× Tetsuya, Higuchi (Gunma Univ)× Yoshito, Tsushima (Gunma Univ)× Ishioka, Noriko× Tetsuya, Sakashita× Shigeki, Watanabe× Yasuhiro, Oshima× Yoko, Ikoma× Ichiro, Sasaki× Tatsuya, Higashi× Noriko, Ishioka |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Objective We aimed to estimate in vivo 211At-labeled meta-benzylguanidine (211At-MABG) absorbed doses by the two dose conversion methods, using 131I-MIBG biodistribution data from a previously reported neuroblastoma xenograft model. Additionally, we examined the effects of different cell lines and time limitations using data from two other works. Methods We used the framework of the Monte Carlo method to create 3200 virtual experimental data sets of activity concentrations (kBq/g) to get the statistical information. Time activity concentration curves were produced using the fitting method of a genetic algorithm. The basic method was that absorbed doses of 211At-MABG were calculated based on the medical internal radiation dose formalism with the conversion of the physical half-life time of 131I to that of 211At. We have further improved the basic method, that is a novel dose conversion method, RAP (RAtio of Pharmacokinetics), using percent injected dose/g. Results Virtual experiments showed that 211At-MABG and 131I-MIBG had similar properties of initial activity concentrations and biological components, but the basic method did not simulate the 211At-MABG dose. Simulated 211At-MABG doses from 131I-MIBG using the RAP method were in agreement with those from 211At-MABG, so that their boxes overlapped in the box plots. The RAP method showed applicability to the different cell lines, but it was difficult to predict long-term doses from short-term experimental data. Conclusions The present RAP dose conversion method could estimate 211At-MABG absorbed doses from the pharmacokinetics of 131I-MIBG with some limitations. The RAP method would be applicable to a large number of subjects for targeted nuclide therapy. |
|||||
| 書誌情報 |
Annals of Nuclear Medicine 巻 35, p. 121-131, 発行日 2020-11 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0914-7187 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.1007/s12149-020-01548-6 | |||||
| 関連サイト | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | https://link.springer.com/article/10.1007/s12149-020-01548-6 | |||||
